Genetic Testing
Genetic Addiction Risk Score (GARS™)
What does your DNA say about you?
Is addiction in your genes?
The power of understanding YOU is now in your hands.
Genetic Addiction Risk Score (GARS™)
What does your DNA say about you?
Is addiction in your genes?
The power of understanding YOU is now in your hands.
Is Addiction in Your Genes?
It’s time to learn about addiction and you. Science and technology have come together to improve addiction medicine and management for people everywhere. The power of understanding YOU is now in your hands. What does your DNA say about you? Your body is a living information system.
Geneus Health is pleased to provide the Genetic Addiction Risk Score (GARS™) test and report. From a simple cheek swab, Geneus Health is able to identify an individual’s genetic predisposition toward addictive behavior.
It’s time to learn about addiction and you. Science and technology have come together to improve addiction medicine and management for people everywhere. The power of understanding YOU is now in your hands. What does your DNA say about you? Your body is a living information system.
Geneus Health is pleased to provide the Genetic Addiction Risk Score (GARS™) test and report. From a simple cheek swab, Geneus Health is able to identify an individual’s genetic predisposition toward addictive behavior.
The Genetic Basis of the GARS™ Test
The development of the Genetic Addiction Risk Score (GARS™) for RDS behaviors captured genetic variation in the brain reward cascade (BRC). The GARS™ Test is a panel of established polymorphisms (gene variations) selected from thousands of studies that associate most with hypodopaminergic (low dopamine) traits. |
Description of GARS™
The GARS™ Test obtains a DNA sample through a non-invasive cheek swab. Swabbing instructions along with an order form and a return prepaid shipping package are included in each kit. The DNA sample is processed and analyzed in Geneus Health’s state-of-the-art, CLIA and CAP certified laboratory. Reporting is 100% confidential. The results yield a report which includes the function of each genetic risk variation, and which RDS variations are found in the individual’s assessment.
Some Clinical Benefits of the GARS™ Test
Use of the GARS™ test in the clinical practical practice could reduce doubt, denial and guilt. It can also predict relapse probability and identify treatment options to include as well as options to avoid. The GARS™ test can corroborate family genograms. It can identify severity based relapse and recovery liabilities. And finally, it can be used to personalize restoreGen™ formulations to the individual's polymorphisms and treatment needs.
GARS™ can be used to corroborate family genograms. Through GARS™ testing, personalized restoreGen™ products can be formulated to the individual’s specific treatment needs.
The GARS™ Test obtains a DNA sample through a non-invasive cheek swab. Swabbing instructions along with an order form and a return prepaid shipping package are included in each kit. The DNA sample is processed and analyzed in Geneus Health’s state-of-the-art, CLIA and CAP certified laboratory. Reporting is 100% confidential. The results yield a report which includes the function of each genetic risk variation, and which RDS variations are found in the individual’s assessment.
Some Clinical Benefits of the GARS™ Test
Use of the GARS™ test in the clinical practical practice could reduce doubt, denial and guilt. It can also predict relapse probability and identify treatment options to include as well as options to avoid. The GARS™ test can corroborate family genograms. It can identify severity based relapse and recovery liabilities. And finally, it can be used to personalize restoreGen™ formulations to the individual's polymorphisms and treatment needs.
GARS™ can be used to corroborate family genograms. Through GARS™ testing, personalized restoreGen™ products can be formulated to the individual’s specific treatment needs.